Frédéric Checler



  • 2014 : “Grand prix” - Pompidou foundation
  • 2013 : "Foreign Corresponding Member" - Brazilian Academy of Sciences 
  • 2013 : Grand Prix Jaffé - French Academy of Sciences
  • 2002 : Prize Charles-Louis de Saulces de Freycinet - French Academy of Sciences
  • 1999 : MHRI Kearney Fellow Award, Mental Health Research Institute


Frédéric Checler received his PhD in Cellular and Molecular Pharmacology from University Nice Sophia Antipolis (1983). He worked first on the field of proteases and neuropeptides metabolism, then moved to the fields of neurodegenerative diseases where he was mainly interested in proteolytic dysfunction and cell death mechanisms involved in Alzheimer’s disease then on dysfunctions taking place in Parkinson’s and prion diseases. More recently, his group has undertaken studies on cerebral cancers with the aim to delineate common denominators between neurodegenerative diseases and tumorigenesis.

Frédéric Checler was ranked top 1% researcher in the world “Biology and Biochemistry” (ISI WOK field of ranking at the end of 2011); he published over 280 articles in international journals, books, monographs, editorials, and reviews; he also attended 225 invitations in international meetings and more than 100 invited seminars. Dr. Checler was the 1st President of the scientific committee of the European League against Alzheimer’s disease (LECMA, 2005-2010), and has been a Member of the steering committee of the French Alzheimer plan launched by President Nicolas Sarkozy. He belongs to the Laboratory of Excellence DistAlz (Development of Innovative STrategies for translational Approach in ALZheimer Disease) that gathers 7 first-class teams.